(Q30410697)

English

Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Generation of recombinant pandemic H1N1 influenza virus with the HA cleavable by bromelain and identification of the residues influencing HA bromelain cleavage (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

5

object named as

Hong Jin

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

author name string

Weijia Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Amorsolo L Suguitan

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

James Zengel

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Zhongying Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

0 references

publication date

13 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

872-878

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Influenza pandemics of the 20th century

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Influenza: lessons from past pandemics, warnings from current incidents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Emergence and pandemic potential of swine-origin H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Bromelain: biochemistry, pharmacology and medical use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

The Location of the Bromelain Cleavage Site in a Hong Kong Influenza Virus Haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

The structure and receptor binding properties of the 1918 influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Crystalline Antigen from the Influenza Virus Envelope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

A DNA transfection system for generation of influenza A virus from eight plasmids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Development of a simple and high-yielding fed-batch process for the production of influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

A rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

The influenza virus resource at the National Center for Biotechnology Information

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Linker and/or transmembrane regions of influenza A/Group-1, A/Group-2, and type B virus hemagglutinins are packed differently within trimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Influenza virus hemagglutinin spike neck architectures and interaction with model enzymes evaluated by MALDI-TOF mass spectrometry and bioinformatics tools.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Antibody recognition of a highly conserved influenza virus epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.101

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.11.101

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30410697&oldid=1794537319"